Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sobi, Inc.
Data (e.g. type of procedure, platelet count, etc.) will be collected retrospectively or prospectively from patient visits occurring within approximately 7 calendar days prior to the first dose of avatrombopag, on Procedure Day, on Discharge Day, and from any clinic visit performed up to 30 days post-procedure. All treatment decisions and clinical assessments will be at the discretion of the treating physician per routine medical care and are not mandated by study design or protocol.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient has thrombocytopenia associated with chronic liver disease and is planned for or underwent treatment with avatrombopag prior to a procedure
Patient provides written informed consent
Minimum Data for Retrospective Enrollment
Platelet count from approximately 7 days prior to starting avatrombopag